THRD (Third Harmonic Bio) Short-Term Debt to Capital
Third Harmonic Bio (THRD) is integrating sustainability principles into the development of immunological drugs by reducing toxic emissions and adhering to trial ethics. The biotech business is optimizing center energy costs and laboratory air filtration. The company currently relies on external capital to test allergy treatments, with the metric standing at 0.00. This chart of quotes for the specific debt-to-equity ratio is provided below.
Analytical breakdowns for Third Harmonic Bio
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Third Harmonic Bio|THRD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Third Harmonic Bio, Inc.|THRD - Aggregate Debt Obligations|Debts to Book Capitalization Third Harmonic Bio Inc.|THRD - Long-Term Debt Volume|Company Short-Term Debt Third Harmonic Bio|Quick Liquidity thirdharmonicbio.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Third Harmonic Bio, Inc
This ratio assesses the company's dependence on short-term borrowed capital relative to its own equity, where a decrease in the indicator minimizes liquidity risks. By analyzing the structure of short-term liabilities relative to capital, an investor can discern the balance between financial stability and investment potential. For Third Harmonic Bio (THRD), this indicator is critical, as excessive debt pressure could limit the funding of clinical trials for the drug THB001.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KALV: Short-Term Debt to Equity Ratio|Septerna Pharma - Short-Term Loans to Capital Ratio|PVLA: Short-Term Debt to Capital|savarapharma.com - Ratio of Short-Term Indebtedness to Capital|RIGL (Rigel Pharmaceuticals, Inc.) - Short-Term Debt to Capital|AnaptysBio Inc (ANAB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Astria Pharma (ATXS)|ENGN (enGene Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital RAPT (RAPT Therapeutics)|JBIO: Short-Term Debt to Capital Ratio|ACRS: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital KYTX (Kyverna Therapeutics Inc.)|TLSA: Short-Term Debt to Capital|Cabaletta Bio Inc - Ratio of Short-Term Indebtedness to Capital|VTYX (Ventyx Biosciences) - Short-Term Debt to Capital|Short-Term Debt to Capital theratech.com|Short-Term Debt to Equity Avalo Therapeutics (AVTX)|ELDN (Eledon Pharmaceuticals Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Agenus Inc AGEN|CLYM - Short-Term Debt to Equity Ratio|ZURA - Short-Term Debt to Equity|Current Liabilities to Capital atyrpharma.com|adagene.com (ADAG) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio IMA|STTK (Shattuck Labs Inc) - Short-Term Debt to Capital|Equillium Bio (EQ) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital CNTB|Short-Term Debt to Equity Ratio immunic-therapeutics.com IMUX|Atara Bio - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital IFRX|X4 Pharma - Short-Term Debt to Capital|ACET: Short-Term Debt to Equity|CELU: Short-Term Debt to Capital|INMB - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Barinthus Biotherapeutics plc|Current Liabilities to Capital Kezar Life Sciences Inc. KZR|Short-Term Debt to Equity Ratio SABS (SAB Biotherapeutics, Inc)|Short-Term Loans to Capital Ratio AKTX|Short-Term Debt to Capital ENLV (Enlivex Therapeutics Ltd.)|Ratio of Short-Term Indebtedness to Capital QTTB|GOVX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital EDSA (Edesa Biotech Inc)|IBIO: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio CARM|Short-Term Debt to Equity XTL Biopharmaceuticals|Bolt Bio - Current Liabilities to Equity|Short-Term Debt to Capital HCWB|APVO (aptevotherapeutics.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AIM (AIM ImmunoTech Inc.)|Short-Term Debt to Capital Aditxt Inc. ADTX|GRI - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital XRTX (xortx.com)|Vyome Holdings (HIND) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Revelation Biosciences Inc|INDP (Indaptus) - Short-Term Debt to Capital|Short-Term Debt to Capital BiondVax Pharmaceuticals|Short-Term Debt to Equity Ratio CALI (CalciMedica, Inc.)|AFMD (affimed.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ALLK (Allakos)|Short-Term Debt to Capital Coefficient HOOKIPA Pharma, Inc. (HOOK)|IGMS - Short-Term Debt to Equity|iTeos Pharma (ITOS) - Short-Term Debt to Equity Ratio|Ocean Biomedical, Inc. (OCEA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio tcbiopharm.com